- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Maternal Prescription Opioid Use linked to Spontaneous Preterm Birth: JAMA
A recent study highlighted the potential risks that are associated with prescription opioid use during pregnancy. The findings of this study were published in the Journal of American Medical Association.
This research examined data from pregnant individuals enrolled in Tennessee Medicaid which spanned over a decade, from 2007 to 2019 and involved over 250,000 patients. Olivia Bosworth and colleagues investigated the association between prescription opioid use during pregnancy and the occurrence of spontaneous preterm birth, which is a significant concern for maternal and child health.
The findings found that among the group studied, over 7% of patients had filled an opioid prescription in the 60 days preceding childbirth. Also, for each doubling of opioid dosage, there was a 4% increase in the risk of spontaneous preterm birth. This explores a dose-dependent relationship between opioid exposure and the risk of preterm delivery.
The study emphasized the importance of these findings in guiding clinical practice. These results support existing recommendations to minimize opioid exposure during pregnancy and to prescribe the lowest effective dose only when necessary. While opioids can be important to manage pain in certain medical conditions, their potential impact on pregnancy outcomes warrants close consideration.
The rigorous methodology of this study utilized a large retrospective cohort that adds strength to its conclusions. Further research may be required to explore the underlying mechanisms that drive this association and to develop targeted interventions for populations at-risk. Overall, the outcomes serve as a crucial addition to the body of evidence linking prescription opioid use during pregnancy to adverse birth outcomes.
Reference:
Bosworth, O. M., Padilla-Azain, M. C., Adgent, M. A., Spieker, A. J., Wiese, A. D., Pham, A., Leech, A. A., Grijalva, C. G., & Osmundson, S. S. (2024). Prescription Opioid Exposure During Pregnancy and Risk of Spontaneous Preterm Delivery. In JAMA Network Open (Vol. 7, Issue 2, p. e2355990). American Medical Association (AMA). https://doi.org/10.1001/jamanetworkopen.2023.55990
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751